Welcome! It's on Thursday 20th June 2013

Beverley Bryant, Director of Strategic Systems and Technology, NHS England

NHS e-Referral Service will replace Choose and Book

Clinical Commissioning Groups have a major role to play in the success of a new e-Referral system that’s part of plans to make the NHS paperless.

read more...
Norman Lamb, Minister of State for Care and Support

Integration is key to NHS future

The NHS should take all possible steps to become an integrated system that dissolves the boundaries separating health, mental health and social care said Norman Lamb, Minister of State for Care and Support (pictured).

read more...
Jeremy Taylor, Chief Executive, National Voices

For patients – is change a loss or a gain?

National Voices and its partners, the NHS Confederation and the Academy of Medical Royal Colleges, are calling for a whole-system approach to changing the health and care system.

read more...
Jeremy Hunt and nurses

Reform argues ring fence stalls progress

Reform has published new research arguing that the ring-fence on the NHS budget should be lifted to speed the pace of NHS innovation.

read more...

NEWS

  • changingnhs.com

    BMA scheme to bring MPs into practices

    GPs are to invite MPs into their practices to take a look at the impact of NHS reforms. The scheme is one of a series of initiatives launched today by the BMA.

PRACTICE BUSINESS

  • Alliance launches network for General practice

    The NHS Alliance has launched a General Practice Network which it says is “the only network in the health sector to support the whole practice team – practice managers, GPs, nurses, and healthcare assistants.”

CLINICAL

NURSING & MIDWIFERY

  • Anna D’Arcy, Public Health Lead for Nutrition and Physical Activity

    School nurses to contact GPs

    School nurses in Wandsworth are beginning to contact local GPs about children at their schools who are classed as very obese, as identified by the National Child Measurement Programme.

PHARMACY

  • EU gives Celgene go-ahead for Revlimid

    The European Commission has granted approval to Revlimid (lenalidomide) for the treatment of patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are failing.

COMMISSIONING